Fayetteville, AR: The consumption of soft-gel caps containing CBD isolate is associated with the alleviation of menstrual-related symptoms (MRS), according to open-label trial data published in the journal Experimental and Clinical Psychopharmacology.
Researchers affiliated with the University of Arkansas and Auburn University in Alabama assessed CBD dosing on MRS in a cohort of 33 subjects. Study participants provided a baseline assessment of their symptom severity. They then consumed CBD gel caps on the days that they experienced MRS symptoms for the following three months.
Subjects reported experiencing immediate relief following their use of CBD. These improvements were sustained over the course of the trial. Subjects also reported reduced stress, irritability, and anxiety following CBD dosing.
The study’s authors concluded: “The present study suggests that CBD may be an effective treatment in alleviating MRS. Given the prevalence of MRS as well as the relative lack of effective options in treating the entirety of experiences that occur because of MRS, further investigation of CBD as an intervention option for MRS is warranted.”
Full text of the study, “Examination of the effects of cannabidiol on menstrual-related symptoms,” appears in Experimental and Clinical Psychopharmacology.